Survivin in cancerology: molecular aspects and therapeutic applications

被引:10
|
作者
Romagnoli, Mathilde [1 ]
Seveno, Celine [1 ]
Bataille, Regis [1 ]
Barille-Nion, Sophie [1 ]
机构
[1] Univ Nantes, INSERM, Dept Rech Cancerol, UMR 892, F-44093 Nantes, France
来源
M S-MEDECINE SCIENCES | 2008年 / 24卷 / 10期
关键词
D O I
10.1051/medsci/20082410821
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Discovered 10 years ago, survivin has a dual role in the smooth progress of mitosis and in apoptosis resistance. Survivin plays an important physiological role in development, but is absent in differentiated adult tissues. In contrast, aberrant survivin expression is found in most human cancers because of the activation of various signalling pathways. A complex survivin network appears to intersect multiple pathways in cell biology, related to several molecular partners and fine subcellular localizations. Based on its pro-oncogenic properties, basic and translational studies have shown a growing interest in survivin that has led to consider survivin as a prognostic marker and a promising target for anti-tumoral therapies.
引用
收藏
页码:821 / 827
页数:7
相关论文
共 50 条
  • [1] Therapeutic progress in cancerology
    Krulik, M
    PRESSE MEDICALE, 1996, 25 (35): : 1667 - 1668
  • [2] Development of therapeutic applications of electropermeabilization in cancerology: level of optical fluoresence imagery
    Ellard, E.
    Blache, M. C.
    Castanier, R.
    Chabot, S.
    Orio, J.
    Paganin-Gioanni, A.
    Golzio, M.
    Teissie, J.
    BULLETIN DU CANCER, 2010, 97 : S55 - S55
  • [3] THERAPEUTIC INDICATIONS IN ORL CANCEROLOGY
    LACCOURREYE, H
    BAILLET, F
    OUEST MEDICAL, 1977, 30 (04): : 159 - 177
  • [4] Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies
    Chen, Xun
    Duan, Ning
    Zhang, Caiguo
    Zhang, Wentao
    JOURNAL OF CANCER, 2016, 7 (03): : 314 - 323
  • [5] ANTISENSE OLIGONUCLEOTIDES - APPLICATIONS IN CANCEROLOGY
    PIERGA, JY
    CAMMILLERI, S
    BENYAHIA, B
    MAGDELENAT, H
    BULLETIN DU CANCER, 1994, 81 (12) : 1023 - 1042
  • [6] Therapeutic perspectives in cancerology for angiogenesis inhibitors
    Bout, JC
    Soncin, F
    Vandenbunder, B
    REVUE DES MALADIES RESPIRATOIRES, 1999, 16 (05) : 854 - 855
  • [7] ARTIFICIAL NUTRITION - THERAPEUTIC ADJUVANT IN CANCEROLOGY
    ROMIEU, C
    SOLASSOL, C
    PUJOL, H
    JOYEUX, H
    SOLASSOL, C
    YAKOUN, M
    THERAPIE, 1978, 33 (04): : 524 - 524
  • [8] EPIDEMIOLOGIC AND THERAPEUTIC ASPECTS OF CANCER IN MADAGASCAR - STUDY THROUGH THE PATIENT POPULATION OF THE CANCEROLOGY DEPARTMENT IN ANTANANARIVO
    PIGNON, T
    RALANTOARIMIHANTA, M
    RATOANINA, JL
    RATSIAHAROVALALA, J
    RAVONIARINORO, A
    ANDRIANJATOVO, J
    JOURNAL EUROPEEN DE RADIOTHERAPIE, 1987, 8 (02): : 77 - 84
  • [9] LOGISTICS OF THERAPEUTIC TRIALS - EXAMPLE OF CANCEROLOGY
    MATHE, G
    KENIS, Y
    BIOMEDICINE, 1973, 18 (03): : 181 - 184
  • [10] Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
    Khan, Zakir
    Khan, Abdul Arif
    Yadav, Hariom
    Prasad, Godavarthi B. K. S.
    Bisen, Prakash Singh
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2017, 22